Danfeng Xu

3.5k citations

142 papers · 1.9k · h-index 26

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Urology top 2%
- Urinary Bladder and Prostate Research

Papers in

Pulmonary and Respiratory Medicine 48
- Prostate Cancer Treatment and Research 19
- Prostate Cancer Diagnosis and Treatment 18
- Renal cell carcinoma treatment 13
Molecular Biology 43
- Epigenetics and DNA Methylation 10

Co-authors: Yi Gao (17 shared papers)Hai Huang (18 shared papers)Hong Yi (13 shared papers)Xiuwu Pan (18 shared papers)Yi Gao (18 shared papers)Lu Chen (13 shared papers)Fajun Qu (14 shared papers)Xingang Cui (13 shared papers)
Journals: Asian Journal of Andrology (5 papers)Oncotarget (4 papers)Cancer Medicine (4 papers)Scientific Reports (4 papers)The Prostate (3 papers)
Partner nations: China Hong Kong United States

In The Last Decade

Danfeng Xu

131 papers receiving 1.9k citations

Peers

Countries citing papers authored by Danfeng Xu

Since Specialization

Citations

This map shows the geographic impact of Danfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Xu more than expected).

Fields of papers citing papers by Danfeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Xu. The network helps show where Danfeng Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Danfeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danfeng Xu Line = papers co-authored together Danfeng Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis Journal of Neuroinflammation ·Danfeng Xu, Di Lian, Jing Wu, Ying Liu, Mingjie Zhu, Jiaming Sun, Dake He, Ling Li	2017	126
2	MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor Molecular and Cellular Biochemistry ·Fajun Qu, Xingang Cui, Hong Yi, Junkai Wang, Li Yao, Lu Chen, Yushan Liu, Yi Gao, Danfeng Xu, Quanxing Wang	2013	81
3	Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta‐analysis British Journal of Urology ·Jingfei Teng, Dongxu Zhang, Yao Li, Lei Yin, Kai Wang, Xingang Cui, Danfeng Xu	2012	70
4	Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells EBioMedicine ·Qin Zhang, Hai Huang, Ao Liu, Li Jiang, Chunying Liu, Bin Sun, Lü Chen, Yi Gao, Danfeng Xu, Changqing Su	2019	69
5	Global analysis of metastasis‐associated gene expression in primary cultures from clinical specimens of clear‐cell renal‐cell carcinoma International Journal of Cancer ·Xiaojie Tan, Yujia Zhai, Wenjun Chang, Jianguo Hou, Songqin He, Liping Lin, Yongwei Yu, Danfeng Xu, Jianru Xiao, Liye Ma, Guoping Wang, Ting-hu CAO, Guangwen Cao	2008	50
6	IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway Cell Death and Disease ·Xi Liu, Lu Chen, Yinghui Fan, Hong Yi, Xiaoqun Yang, Yao Li, Jianlei Lü, Jian‐Min Lv, Xiuwu Pan, Fajun Qu, Xingang Cui, Yi Gao, Danfeng Xu	2019	50
7	Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion Molecular Medicine Reports ·Jie Chen, Zhijun Wang, Danfeng Xu, Yushan Liu, Yi Gao	2014	44
8	DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling Oncogene ·David W. Chan, Winnie W. Hui, Junwen Wang, Mingo M. H. Yung, L M N Hui, Yuxiao Qin, R R Liang, Thomas H. Y. Leung, Danfeng Xu, Kkl Chan, KM Yao, Benjamin K. Tsang, Hys Ngan	2016	43
9	EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation EBioMedicine ·Hai Huang, Yi Gao, Ao Liu, Xiaoqun Yang, Fang Huang, Le Xu, Danfeng Xu, Lu Chen	2019	41
10	Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts Briefings in Bioinformatics ·Chuanjie Zhang, Tianhe Chen, Zongtai Li, Ao Liu, Xu Yang, Yi Gao, Danfeng Xu	2020	40
11	EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling International Journal of Oncology ·Xiuwu Pan, Lu Chen, Hong Yi, Danfeng Xu, Xi Liu, Lin Li, Yi Huang, Liming Cui, Sishun Gan, Qiwei Yang, Hai Huang, Fajun Qu, Jian-Qing Ye, Linhui Wang, Xingang Cui	2016	39
12	Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma Cell Metabolism ·Chuanjie Zhang, Zunguo Du, Yi Gao, Kiat Shenq Lim, Wenjie Zhou, Hai Huang, Hongchao He, Jun Xiao, Danfeng Xu, Qingquan Li	2024	39
13	Risk factor for clear cell renal cell carcinoma in Chinese population: A case–control study Cancer Epidemiology ·Guoping Wang, Jianguo Hou, Liye Ma, Jiaxin Xie, Jianhua Yin, Danfeng Xu, Wenjun Chang, Xiaojie Tan, Tong Su, Hongwei Zhang, Guangwen Cao	2011	38
14	Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation Oncotarget ·Yi Huang, Xiuwu Pan, Lin Li, Lu Chen, Xi Liu, Jianlei Lü, Xiaomei Zhu, Hai Huang, Qiwei Yang, Jian-Qing Ye, Sishun Gan, Linhui Wang, Hong Yi, Danfeng Xu, Xingang Cui	2016	38
15	Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial British Journal Of Nutrition ·Danfeng Xu, Jianqin Sun, Min Chen, Yanqiu Chen, Hua Xie, Wei-Jia Sun, Yifan Lin, Jingjing Jiang, Wei Sun, Aifang Chen, Qian-Ru Tang	2012	37
16	Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma Aging ·Chuanjie Zhang, Hongchao He, Xin Hu, Ao Liu, Da Huang, Yang Xu, Lu Chen, Danfeng Xu	2019	35
17	Infection‑provoked psoriasis: Induced or aggravated (Review) Experimental and Therapeutic Medicine ·Yan Teng, Wenqing Xie, Xiaohua Tao, Na Liu, Yong Yu, Youming Huang, Danfeng Xu, Yibin Fan	2021	33
18	Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy Oncology Reports ·Xiuwu Pan, Lin Li, Yi Huang, Hai Huang, Danfeng Xu, Yi Gao, Lu Chen, Jizhong Ren, Jianwei Cao, Hong Yi, Xingang Cui	2015	32
19	Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis The Aging Male ·Xiaoqiang Qian, Hailong Liu, Ding Xu, (unknown), Le Xu, Fang Huang, Wei He, Jun Qi, Yu Zhu, Danfeng Xu	2017	32
20	Sunitinib dosing schedule 2/1 improves tolerability, efficacy, and health-related quality of life in Chinese patients with metastatic renal cell carcinoma Urologic Oncology Seminars and Original Investigations ·Xiuwu Pan, Hai Huang, Yi Huang, Bing Liu, Xingang Cui, Sishun Gan, Jianqing Ye, Danfeng Xu, Lu Chen, Qiwei Zhou, Lin Li, Hong Yi	2015	31

About Danfeng Xu

Danfeng Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Oncology, having authored 142 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Renal cell carcinoma treatment (13 papers), Bladder and Urothelial Cancer Treatments (11 papers), Epigenetics and DNA Methylation (10 papers), Adrenal and Paraganglionic Tumors (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (329 citations), Urology (133 citations), Pulmonary and Respiratory Medicine (412 citations), Molecular Biology (753 citations) and Oncology (199 citations). Danfeng Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yi Gao, Hai Huang, Hong Yi, Xiuwu Pan, Yi Gao, Lu Chen, Fajun Qu, Xingang Cui, Hongchao He and Ling Li. Their work appears in journals such as Asian Journal of Andrology, Oncotarget, Cancer Medicine, Scientific Reports and The Prostate.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Danfeng Xu

Impact in

Papers in i

In The Last Decade

Danfeng Xu

Peers

Countries citing papers authored by Danfeng Xu

Fields of papers citing papers by Danfeng Xu

All Works

About Danfeng Xu

Explore authors with similar magnitude of impact

Papers in